Last Updated : Friday, January 17, 2020 15:34:11

News of Licenses | Approvals | Permissions in Gujarat

NCLT nods merger of subsidiaries with BOROSIL GLASS WORKS

MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered houseware products manufacturing company Borosil Glass Works Ltd said of NCLT (National Company Law Tribunal) Mumbai bench having sanctioned and approved merger between Vyline Glass Works Ltd, Fennel Investment and Finance Pvt Ltd, Gujarat Borosil Ltd into Borosil

India’s First New Discovery Antibiotics from WOCKHARDT gets Regulatory nod

MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceuticals company Wockhardt Ltd said of having got Indian Regulatory approval for India’s first new discovery of antibiotics. The press-release titled, “India’s First New Discovery Antibiotics from Wockhardt Granted Indian Regulatory Approval”, enclosed with the regulatory filing as

STRIDES PHARMA gets USFDA nod to market nasal treatment drug

BANGALORE | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Bangalore headquartered Strides Pharma Science Ltd said of having USFDA (US Food and Drugs Administration) nod to market nasal treatment drug – Loratadine OTC Softgel Capsules in 10 mg dosage value. The press-release titled, “Strides receives USFDA approval for Loratadine OTC Softgel Capsules”, enclosed with

ALEMBIC PHARMA gets USFDA nod to market anti-diabetic drug

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara headquartered Indian Pharmaceutical products manufacturing major – Alembic Pharmaceuticals Ltd said of having got tentative approval for marketing anti-diabetic drug – Empagliflozin Tablets in dosages of 10 mg (milligram) and 25 mg, primely aimed to substitute

ALEMBIC PHARMA gets USFDA nod to market anti-spasm drug

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Indian pharmaceutical major – Alembic Pharmaceuticals Ltd said of having got approval to market anti-spasm (muscle contraction) drug. The release titled, “Alembic Pharmaceuticals announces USFDA Final Approval for Tizanidine Hydrochloride Capsules, 2 mg, 4

SUN PHARMA inks pact to commercialize haemoglobin maintenance drug

MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered Indian Pharma Major – Sun Pharmaceuticals Ltd said of having inked licensing agreement with US based Rockwell Medical, for commercializing Triferic, a drug used for iron replacement and haemoglobin maintenance, for treating anaemia in hemodialysis patients in India.

LINDE INDIA’s board approves CCI orders, on divestment of Belloxy Biz

KOLKATA | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Linde India Ltd, Kolkata headquartered Indian arm of Industrial Gases manufacturing multinational Linde Group, said of the company board having approved the Competition Commission of India’s compliance orders for sale/divestment of the company’s Belloxy Business, in a Board

ALEMBIC PHARMA gets USFDA nod to market depressive disorder treatment

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered India pharmaceutical major – Alembic Pharmaceuticals receives USFDA Final Approval for drug Vilazodone Hydrochloride Tablets in 10 mg. 20 mg, and 40 mg dosage, which is used to treat depressive disorder and had a

Govt of India launches, DIGITAL LICENSING for ROAD PETRO TANKERS

NEW DELHI | RAJKOT – In a press-release issued by Press Information Bureau (PIB) of India – press & publicity arm of Indian Government, it read that Department for Promotion of Industry and Internal Trade (DPIIT) under the aegis of Ministry of Commerce & Industries launched paperless licensing process through Petroleum and Safety Organization (PESO)

CABINET approved INDO-FRENCH pact of Migration & Mobiity Partnership

NEW DELHI | RAJKOT – In a press-release issued by Press Information of Bureau (PIB), press & publicity arm of Government of India, it read of the Union Cabinet having approved ratification of Migration and Mobility partnership agreement between India and France. Cabinet approves ratification of Migration and Mobility Partnership Agreement between India and France

GLENMARK PHARMA gets USFDA nod to mkt tablets to treat excess iron

MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Indian Pharmaceutical company Glenmark Pharmaceuticals Ltd said of having got nod from USFDA (US Food and Drugs Administration) to market tablet to treat excess iron in the body, usually such iron overload is created due to blood transfusion in adults

ALEMBIC PHARMA gets USFDA nod to market opthalmic treatement

VADODARA (BARODA) | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Indian Pharma company – Alembic Pharmaceuticals Ltd said of having got USFDA (US Food & Drugs Administration) nod to market ophthalmic treatment – Travoprost Opthalmic Solution USP, 0.004%. The approved abbreviated new drug application

GLENMARK PHARMA gets approval to market nasal-treatment in AUSTRALIA

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered Indian Pharmaceutical company Glenmark Pharmaceuticals Ltd said of having announced approval market medicine – Ryaltris® to treat nasal (nose) related disorders, in Australia. In a press-release as communicated by the company to the Indian Bourses, titled

CONCORD BIOTECH got nod to mkt medicine to treat Nephro disorders

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered Indian pharma major Lupin Ltd said of its alliance partner Concord Biotech Ltd having got nod from USFDA (US Food & Drugs Administration) to market medicine to treat nephro (kidney) related disorders. The press-release as submitted

ZYDUS CADILA gets USFDA nod to market affordable anti-diabetic tablet

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr Pankaj Patel owned Zydus Group’s pharma arm Cadila Healthcare Ltd said of having got nod from USFDA (US Food and Drugs Administration) to market an affordable anti-diabetic tablet Vinglyn, which is now one of the most

CCI nods NIPPON EXPRESS’ acquisition in FUTURE SUPPLY CHAIN SOLUTIONS

NEW DELHI | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a press release as issued by Competition Commission of India, the regulatory body said of having given nod to proposed acquisition by Nippon Express (South Asia & Oceania) Pte. Ltd in Future Supply Chain Solutions Ltd, under the Section 31(1) of the Competition Act, 2002.

Do NOT follow this link or you will be banned from the site!